Position in ABBV
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$1,459,260
+$243,274 QoQ
Shares Held
5,799
+3.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#2,199
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 81%
Shared 0%
None 19%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GHP Investment Advisors, Inc. holds $46,475,498 across 14 Drug Manufacturers - General names. ABBV ranks #6 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
118,345 | $15,207,332 | |
| 2 | JNJ |
Johnson & Johnson
|
58,033 | $14,738,640 | |
| 3 | AMGN |
Amgen Inc
|
28,143 | $10,191,142 | |
| 4 | LLY |
ELI LILLY & Co
|
1,816 | $2,178,165 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
12,971 | $1,638,755 | |
| 6 | ABBV |
AbbVie Inc.
This page
|
5,799 | $1,459,260 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
5,952 | $342,954 | |
| 8 | NVO |
Novo Nordisk A S
|
4,826 | $231,358 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,459,260 | 5,799 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $1,215,986 | 5,591 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $1,336,894 | 5,851 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $1,333,438 | 5,759 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $1,081,050 | 5,824 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $1,264,662 | 6,036 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $1,058,558 | 5,957 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $1,207,590 | 6,115 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $994,987 | 5,801 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $1,039,973 | 5,711 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $892,782 | 5,761 | Shares | Sole | 2024-01-26 | |
| 2023-09-30 | $937,140 | 6,287 | Shares | Sole | 2023-10-17 | |
| 2023-06-30 | $790,730 | 5,869 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $899,324 | 5,643 | Shares | Sole | 2023-04-21 | |
| 2022-12-31 | $952,044 | 5,891 | Shares | Sole | 2023-02-16 | |
| 2022-09-30 | $783,920 | 5,841 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $894,760 | 5,842 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $1,005,082 | 6,200 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $846,656 | 6,253 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $791,765 | 7,340 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $857,190 | 7,610 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $646,614 | 5,975 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $617,719 | 5,765 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $505,744 | 5,774 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $573,174 | 5,838 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $624,986 | 8,203 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||